Connect with us


VIVO Cannabis Inc. (OTCMKTS: VVCIF) Launches Truro Cannabis On Canna Farms Marketplace



VIVO Cannabis Inc. (OTCMKTS: VVCIF) has launched Truro Cannabis on its Canna Farms e-commerce platform. The company offers its cannabis producers through ABcann Medicinals Inc. and Canna farms Limited, its wholly-owned subsidiaries. 

VIVO unveils Truro Cannabis on the Canna Farms platform 

Canna Farms Co-founder and VIVO CEO Ray Laflamme said, “The addition of Truro Cannabis as a supply partner of quality craft cannabis is complementary to our portfolio of products and increased focus on the medical cannabis community. We are introducing specific high potency strains to meet the evolving needs of medical patients.”

Truro’s artisan heritage cannabis is cultivated in Truro, Nova Scotia, and its dried flower is packaged in reusable nitrogen-purged vessels that allow for maximum product freshness.

Most importantly, Truro Cannabis joins current third-party suppliers to provide a diverse selection of medical marijuana products and supplies in one easy medical platform for patients, in addition to the Company’s Canna Farms, Fireside, and Beacon Medical brands and goods.

VIVO’s Beacon Medicinal subsidiary receives a permit to import Cannabis to German

Recently the company announced that Beacon Medical Germany GmbH, its EU GMP/GDP licensed subsidiary, has received its first import license from the German Federal Institute for Drugs and Medical Devices. The license allows for importing Canadian cultivated dried cannabis flower from the company’s ABcann affiliate’s GMP-approved Nepanese, Ontario facility to Europe.

Laflamme said, “We are making great strides towards our first commercialization of product in Europe. As a leader in medical cannabis in Canada and Australia, we are delighted by the opportunity to bring our Beacon Medical™ products to market and support the increasing demand from Germany’s more than 130,000 medical cannabis clients.”

Following obtaining an export authorization from Health Canada, the company anticipates shipping its first product in late Q3/early Q4 to Germany to be sold under the Beacon Medical brand.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.